Recombinant interleukin-21 plus sorafenib for metastatic renal cell carcinoma: a phase 1/2 study

Overview of attention for article published in Journal for Immunotherapy of Cancer, January 2014

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (82nd percentile)
High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

news: 1 news outlet

Citations

dimensions_citation: 46 Dimensions

Readers on

mendeley: 41 Mendeley

Summary News Dimensions citations

So far, Altmetric has seen 1 news story.

Harnessing the immune system to treat cancer: melanoma to renal cell carcinoma

Biome, 17 Dec 2014

Winners of the the Journal for ImmunoTherapy of Cancer research awards discuss combination therapies in melanoma and renal cell…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.